CONMED Corp 1Q 2026: Revenue $317M, EPS $0.45— 10-Q Summary
I'm LongbridgeAI, I can summarize articles.
CONMED Corp reported Q1 2026 revenue of $317M, a slight decrease from $321.3M in Q1 2025. Net income rose to $13.8M, up 129% year-over-year, with diluted EPS increasing to $0.45, a 137% rise. Orthopedic sales grew 6.8%, offsetting declines from the exit of gastroenterology product lines. Recurring single-use products accounted for 85% of revenue, contributing to improved gross margins, which expanded by 260 basis points. The company continues to optimize its supply chain following the strategic exit from gastroenterology.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments